RIGL
Rigel Pharmaceuticals Inc
48.20$
+0.6%
vs. previous close
Closing price · As of: Sep 25, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | +7,078.5% | -33.1% | -106.2% | – | -21.3% | -8.5% | -87.6% | +1,024.9% | – | |
| – | +0.3% | +36.5% | +53.3% | -0.3% | -1.1% | +0.0% | +0.5% | -0.7% | -0.3% | -0.7% | +42.0% | – | |
| – | -0.5% | +165.6% | -50.8% | +4.6% | -21.1% | +59.3% | -1.4% | +2.7% | -18.3% | +25.8% | +98.0% | – | |
| – | -497.0% | – | – | – | -136.0% | – | – | -201.3% | – | – | – | – | |
| – | +400.0% | +25.5% | +60.9% | -95.5% | +160.0% | -100.0% | – | – | +0.0% | -100.0% | – | – | |
| – | +487.5% | – | +3,391.7% | -65.2% | -387.1% | -3.3% | +120.6% | +42.5% | -23.6% | -68.6% | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | +3.3% | – | |
| – | – | -616.9% | -70.1% | +1,208.8% | – | -67.0% | -13.6% | +921.8% | -207.0% | +138.8% | +7.2% | – | |
| – | – | – | – | +49.2% | -67.7% | -316.9% | – | -163.5% | – | – | – | – | |
| – | – | – | – | +26,986.3% | -33.2% | -106.2% | – | -21.3% | -8.4% | -87.6% | +1,024.9% | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.